Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Joining the ranks and reaching a $1 trillion valuation is a milestone. But staying there is also a challenge. Eli Lilly (NYSE: LLY) became the first healthcare company to reach $1 trillion in market cap last year. However, given its poor start to 2026, it has fallen well below that. Entering trading on Monday, the company's valuation was around $830 billion. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » There has been more excitement around the stock lately with the approval of its GLP-1 weight loss pill. Could that give the stock the boost it needs to get back to a $1 trillion valuation this year? Image source: Getty Images. A stronger growth rate could lead to much more bullishness On April 1, the Food and Drug Administration approved Foundayo, which is Eli Lilly's weight loss drug. The pill will be
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly (LLY): 3 Reasons We Love This Stock [Yahoo! Finance]Yahoo! Finance
- Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisition [Yahoo! Finance]Yahoo! Finance
- Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies [TheStreet.com]TheStreet.com
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapiesPR Newswire
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- 3/20/26 - Form DEF
- LLY's page on the SEC website